Ulcerative colitis
Conditions
Interventions
None listed
Sponsors
Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Outpatients 2) Adult patients who have been diagnosed as ulcerative colitis according to the diagnostic criteria for ulcerative colitis (draft revised on January 26, 2012) 3) Those who are diagnosed in the clinically remission stage (PGA=0) 4) Patients who were induced remission with SASP, mesalazine, steroid or immunomodulator and are maintained with those drugs 5) Patients who have received adequate information regarding this study and understood thoroughly, and then voluntarily submitted written consent forms upon participation in this study
Exclusion criteria
Exclusion criteria: 1) Patients who have received total / subtotal colectomy 2) Patients who have been complicated or have history with malignant tumor 3) Patients who were induced or maintained remission with biologics 4) Patients who needed dose-increase or addition of drug for maintenance of remission during study period 5) Patients who are pregnant or possibly pregnant 6) Other patients whom investigators and subinvestigators considered inappropriate to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association between I-FOBT and UCCIS | — |
Secondary
| Measure | Time frame |
|---|---|
| relapse rate and time to relapse | — |
Countries
Japan
Contacts
Public ContactTomohisa Takagi
Kyoto Prefectural University of Medicine Molecular Gastroenterology and Hepatology
Outcome results
None listed